ILevetiracetam LEV CAS 102767-28-2 API Factory USP EP Standard High Purity

Inkcazelo emfutshane:

Igama leKhemikhali: Levetiracetam;LEV

CAS: 102767-28-2

Imbonakalo: Umgubo weCrystals oMhlophe okanye ophantse waMhlophe

Uvavanyo: 98.0% ~ 102.0%

Isizukulwana sesithathu se-Antiepileptic Drug

Umgangatho ophezulu we-API, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Levetiracetam
CAS: 102767-28-2
I-API USP / EP Standard, iMveliso yoRhwebo
Isizukulwana sesithathu se-Antiepileptic Drug

Iipropati zeMichiza:

Igama leMchiza	Levetiracetam
Izithethantonye	LEV;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;UCB-L059
Inombolo yeCAS	102767-28-2
Inombolo yeCAT	RF-API61
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C8H14N2O2
Ubunzima beMolekyuli	170.21
Indawo yokunyibilika	116.0-119.0℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye ophantse wamhlophe
Ukuchongwa kwe-IR	ISpectrum efunyenwe kwisampulu iqulathe leyo ifunyenwe kwireferensi
Imbonakalo yesisombululo	Icacile kwaye ingabi mbala kakhulu kune-BY6
Ukungcola kwe-Enantiomeric D	≤0.80%
Amanzi	≤0.50%
Uthuthu lweSulfated	≤0.10%
Iintsimbi ezinzima	≤0.001%
Izinto ezinxulumeneyo
Ukungcola A	≤0.30%
Nakuphi na Ukungcola Okungachazwanga	≤0.05%
Ukungcola okungachazwanga ngokupheleleyo	≤0.10%
Ukungcola ngokupheleleyo	≤0.40%
Ukungcola F	≤0.10%
Izinyibilikisi ezishiyekileyo
Benzeni	≤2ppm
Dichloromethane	≤600ppm
I-Ethyl Acetate	≤5000ppm
I-acetone	≤5000ppm
Isivavanyi	98.0%~102.0%
Umgangatho woVavanyo	Umgangatho we-USP;EP Umgangatho
Ukusetyenziswa	API Isizukulwana Sesithathu Antiepileptic Drug

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Levetiracetam (i-CAS: i-102767-28-2), i-derivative ye-pilacetam, iyinoveli ye-antiepileptic yesizukulwana sesithathu esivunywe yi-US FDA kwi-1999. Ekuqaleni yayisetyenziselwa unyango oluncedisayo lokubanjwa okuyingxenye kubantu abadala.Kwi-2005, i-Levetiracetam yavunywa kwiipilisi zomlomo kunye nezisombululo zonyango oluncedisayo lokubanjwa okuyingxenye kubantwana abaneminyaka eyi-4 nangaphezulu.Isetyenziswa ikakhulu kunyango olongezelelweyo lokuxhuzula inxalenye yabantu abadala kunye nabantwana abangaphezu kweminyaka emi-4 ubudala, kwaye ingasetyenziselwa kuphela ukuxhuzula okuyingxenye kunye nokuxhuzula kwenkqubo kubantu abadala.Ikwanazo nefuthe elithile lokunyanga kwi-myoclonic epilepsy kulutsha, ukuxhuzula okunqandayo, ukuxhuzula okungabikho ebantwaneni kunye nokuxhuzula okuzingisileyo.